{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:41:33Z","timestamp":1790444493172,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:00:00Z","timestamp":1412035200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s13023-014-0131-7","type":"journal-article","created":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T15:48:57Z","timestamp":1412005737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition"],"prefix":"10.1186","volume":"9","author":[{"given":"Vip","family":"Viprakasit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarayuth","family":"Rodmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali T","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,30]]},"reference":[{"key":"131_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2007.06654.x","volume":"138","author":"C Borgna-Pignatti","year":"2007","unstructured":"Borgna-Pignatti C: Modern treatment of thalassaemia intermedia. Br J Haematol. 2007, 138: 291-304. 10.1111\/j.1365-2141.2007.06654.x.","journal-title":"Br J Haematol"},{"key":"131_CR2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2010.05550.x","volume":"1202","author":"C Borgna-Pignatti","year":"2010","unstructured":"Borgna-Pignatti C, Marsella M, Zanforlin N: The natural history of thalassemia intermedia. Ann N Y Acad Sci. 2010, 1202: 214-220. 10.1111\/j.1749-6632.2010.05550.x.","journal-title":"Ann N Y Acad Sci"},{"key":"131_CR3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2141.2010.08486.x","volume":"152","author":"AT Taher","year":"2011","unstructured":"Taher AT, Musallam KM, Cappellini MD, Weatherall DJ: Optimal management of beta thalassaemia intermedia. Br J Haematol. 2011, 152: 512-523. 10.1111\/j.1365-2141.2010.08486.x.","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"131_CR4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0268-960X(12)70003-6","volume":"26","author":"DJ Weatherall","year":"2012","unstructured":"Weatherall DJ: The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev. 2012, 26 (Suppl 1): S3-S6. 10.1016\/S0268-960X(12)70003-6.","journal-title":"Blood Rev"},{"key":"131_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","volume":"5","author":"R Galanello","year":"2010","unstructured":"Galanello R, Origa R: Beta-thalassemia. Orphanet J Rare Dis. 2010, 5: 11-10.1186\/1750-1172-5-11.","journal-title":"Orphanet J Rare Dis"},{"key":"131_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1172-5-13","volume":"5","author":"CL Harteveld","year":"2010","unstructured":"Harteveld CL, Higgs DR: Alpha-thalassaemia. Orphanet J Rare Dis. 2010, 5: 13-10.1186\/1750-1172-5-13.","journal-title":"Orphanet J Rare Dis"},{"key":"131_CR7","first-page":"339","volume":"80","author":"HL Muncie Jr","year":"2009","unstructured":"Muncie HL, Campbell J: Alpha and beta thalassemia. Am Fam Physician. 2009, 80: 339-344.","journal-title":"Am Fam Physician"},{"key":"131_CR8","first-page":"237","volume-title":"The Thalassemia Syndromes","author":"DR Higgs","year":"2001","unstructured":"Higgs DR, Thein SL, Wood WG: Distribution and population genetics of the thalassaemias. The Thalassemia Syndromes. Edited by: Weatherall DJ, Clegg JB. 2001, Blackwell Science, Ltd, London, 237-284."},{"key":"131_CR9","doi-asserted-by":"crossref","first-page":"D537","DOI":"10.1093\/nar\/gkh006","volume":"32","author":"GP Patrinos","year":"2004","unstructured":"Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, Wajcman H, Hardison RC: Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004, 32: D537-D541. 10.1093\/nar\/gkh006.","journal-title":"Nucleic Acids Res"},{"key":"131_CR10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12185-009-0432-0","volume":"90","author":"V Viprakasit","year":"2009","unstructured":"Viprakasit V, Lee-Lee C, Chong QT, Lin KH, Khuhapinant A: Iron chelation therapy in the management of thalassemia: the Asian perspectives. Int J Hematol. 2009, 90: 435-445. 10.1007\/s12185-009-0432-0.","journal-title":"Int J Hematol"},{"key":"131_CR11","unstructured":"Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001, 79: 704-712."},{"key":"131_CR12","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","volume":"115","author":"DJ Weatherall","year":"2010","unstructured":"Weatherall DJ: The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010, 115: 4331-4336. 10.1182\/blood-2010-01-251348.","journal-title":"Blood"},{"key":"131_CR13","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2141.2008.07085.x","volume":"141","author":"DJ Weatherall","year":"2008","unstructured":"Weatherall DJ: Genetic variation and susceptibility to infection: the red cell and malaria. Br J Haematol. 2008, 141: 276-286. 10.1111\/j.1365-2141.2008.07085.x.","journal-title":"Br J Haematol"},{"key":"131_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.1998.tb10489.x","volume":"850","author":"R Galanello","year":"1998","unstructured":"Galanello R, Cao A: Relationship between genotype and phenotype: thalassemia intermedia. Ann N Y Acad Sci. 1998, 850: 325-333. 10.1111\/j.1749-6632.1998.tb10489.x.","journal-title":"Ann N Y Acad Sci"},{"key":"131_CR15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2141.2003.04769.x","volume":"124","author":"SL Thein","year":"2004","unstructured":"Thein SL: Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol. 2004, 124: 264-274. 10.1046\/j.1365-2141.2003.04769.x.","journal-title":"Br J Haematol"},{"key":"131_CR16","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00043426-200011000-00022","volume":"22","author":"S Fucharoen","year":"2000","unstructured":"Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P: Clinical manifestation of beta-thalassemia\/hemoglobin E disease. J Pediatr Hematol Oncol. 2000, 22: 552-557. 10.1097\/00043426-200011000-00022.","journal-title":"J Pediatr Hematol Oncol"},{"key":"131_CR17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bcmd.2011.02.004","volume":"46","author":"ME Lai","year":"2011","unstructured":"Lai ME, Vacquer S, Carta MP, Spiga A, Cocco P, Angius F, Mandas A, Dessi S: Thalassemia intermedia is associated with a proatherogenic biochemical phenotype. Blood Cells Mol Dis. 2011, 46: 294-299. 10.1016\/j.bcmd.2011.02.004.","journal-title":"Blood Cells Mol Dis"},{"key":"131_CR18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJMoa1010174","volume":"364","author":"A Lal","year":"2011","unstructured":"Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP: Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011, 364: 710-718. 10.1056\/NEJMoa1010174.","journal-title":"N Engl J Med"},{"key":"131_CR19","doi-asserted-by":"crossref","first-page":"a013482","DOI":"10.1101\/cshperspect.a013482","volume":"2","author":"KM Musallam","year":"2012","unstructured":"Musallam KM, Taher AT, Rachmilewitz EA: Beta-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012, 2: a013482-10.1101\/cshperspect.a013482.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"131_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcmd.2006.04.005","volume":"37","author":"A Taher","year":"2006","unstructured":"Taher A, Isma\u2019eel H, Cappellini MD: Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006, 37: 12-20. 10.1016\/j.bcmd.2006.04.005.","journal-title":"Blood Cells Mol Dis"},{"key":"131_CR21","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2009-09-243154","volume":"115","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD: Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010, 115: 1886-1892. 10.1182\/blood-2009-09-243154.","journal-title":"Blood"},{"issue":"Suppl 1","key":"131_CR22","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0268-960X(12)70005-X","volume":"26","author":"S Rivella","year":"2012","unstructured":"Rivella S: The role of ineffective erythropoiesis in non-transfusion dependent thalassemia. Blood Rev. 2012, 26 (Suppl 1): S12-S15. 10.1016\/S0268-960X(12)70005-X.","journal-title":"Blood Rev"},{"key":"131_CR23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MOH.0b013e32832990a4","volume":"16","author":"S Rivella","year":"2009","unstructured":"Rivella S: Ineffective erythropoiesis and thalassemias. Curr Opin Hematol. 2009, 16: 187-194. 10.1097\/MOH.0b013e32832990a4.","journal-title":"Curr Opin Hematol"},{"key":"131_CR24","volume-title":"Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management","author":"NF Olivieri","year":"2009","unstructured":"Olivieri NF, Weatherall DJ: Clinical aspects of B-thalassemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Edited by: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. 2009, Cambridge University Press, Cambridge"},{"key":"131_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM199907083410207","volume":"341","author":"NF Olivieri","year":"1999","unstructured":"Olivieri NF: The beta-thalassemias. N Engl J Med. 1999, 341: 99-109. 10.1056\/NEJM199907083410207.","journal-title":"N Engl J Med"},{"key":"131_CR26","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2010.08220.x","volume":"150","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, El-Beshlawy A, Karimi M, Daar S, Belhoul K, Saned MS, Graziadei G, Cappellini MD: Age-related complications in treatment-naive patients with thalassaemia intermedia. Br J Haematol. 2010, 150: 486-489.","journal-title":"Br J Haematol"},{"key":"131_CR27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MPH.0b013e3182431ddb","volume":"34","author":"A Doulgeraki","year":"2012","unstructured":"Doulgeraki A, Athanasopoulou H, Voskaki I, Tzagaraki A, Karabatsos F, Fragodimitri C, Georgakopoulou E, Iousef J, Monopolis I, Chatziliami A, Karagiorga M: Bone health evaluation of children and adolescents with homozygous beta-thalassemia: implications for practice. J Pediatr Hematol Oncol. 2012, 34: 344-348. 10.1097\/MPH.0b013e3182431ddb.","journal-title":"J Pediatr Hematol Oncol"},{"key":"131_CR28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.bone.2011.07.014","volume":"49","author":"AG Pirinccioglu","year":"2011","unstructured":"Pirinccioglu AG, Akpolat V, Koksal O, Haspolat K, Soker M: Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone. 2011, 49: 819-823. 10.1016\/j.bone.2011.07.014.","journal-title":"Bone"},{"key":"131_CR29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.080505","volume":"24","author":"MG Vogiatzi","year":"2009","unstructured":"Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ: Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009, 24: 543-557. 10.1359\/jbmr.080505.","journal-title":"J Bone Miner Res"},{"key":"131_CR30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(79)92175-5","volume":"2","author":"MJ Pippard","year":"1979","unstructured":"Pippard MJ, Callender ST, Warner GT, Weatherall DJ: Iron absorption and loading in beta-thalassaemia intermedia. Lancet. 1979, 2: 819-821. 10.1016\/S0140-6736(79)92175-5.","journal-title":"Lancet"},{"key":"131_CR31","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V71.4.1124.1124","volume":"71","author":"P Pootrakul","year":"1988","unstructured":"Pootrakul P, Kitcharoen K, Yansukon P, Wasi P, Fucharoen S, Charoenlarp P, Brittenham G, Pippard MJ, Finch CA: The effect of erythroid hyperplasia on iron balance. Blood. 1988, 71: 1124-1129.","journal-title":"Blood"},{"key":"131_CR32","doi-asserted-by":"crossref","first-page":"358283","DOI":"10.1155\/2010\/358283","volume":"2010","author":"T Tanno","year":"2010","unstructured":"Tanno T, Miller JL: Iron loading and overloading due to ineffective erythropoiesis. Adv Hematol. 2010, 2010: 358283-10.1155\/2010\/358283.","journal-title":"Adv Hematol"},{"key":"131_CR33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1160\/TH06-05-0267","volume":"96","author":"A Taher","year":"2006","unstructured":"Taher A, Isma\u2019eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, Cappellini MD: Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006, 96: 488-491.","journal-title":"Thromb Haemost"},{"key":"131_CR34","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/j.1538-7836.2010.03940.x","volume":"8","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned M, Cesaretti C, Cappellini MD: Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost. 2010, 8: 2152-2158. 10.1111\/j.1538-7836.2010.03940.x.","journal-title":"J Thromb Haemost"},{"key":"131_CR35","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1182\/blood-2003-11-3957","volume":"103","author":"V Viprakasit","year":"2004","unstructured":"Viprakasit V, Tanphaichitr VS, Chinchang W, Sangkla P, Weiss MJ, Higgs DR: Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. Blood. 2004, 103: 3296-3299. 10.1182\/blood-2003-11-3957.","journal-title":"Blood"},{"key":"131_CR36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00277-009-0743-5","volume":"88","author":"V Laosombat","year":"2009","unstructured":"Laosombat V, Viprakasit V, Chotsampancharoen T, Wongchanchailert M, Khodchawan S, Chinchang W, Sattayasevana B: Clinical features and molecular analysis in Thai patients with HbH disease. Ann Hematol. 2009, 88: 1185-1192. 10.1007\/s00277-009-0743-5.","journal-title":"Ann Hematol"},{"key":"131_CR37","doi-asserted-by":"crossref","unstructured":"Fucharoen S, Viprakasit V: Hb H disease: clinical course and disease modifiers.Hematology Am Soc Hematol Educ Program 2009:26-34.,","DOI":"10.1182\/asheducation-2009.1.26"},{"issue":"Suppl 1","key":"131_CR38","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S0268-960X(12)70009-7","volume":"26","author":"NF Olivieri","year":"2012","unstructured":"Olivieri NF: Treatment strategies for hemoglobin E beta-thalassemia. Blood Rev. 2012, 26 (Suppl 1): S28-S30. 10.1016\/S0268-960X(12)70009-7.","journal-title":"Blood Rev"},{"key":"131_CR39","first-page":"929","volume":"84","author":"V Viprakasit","year":"2001","unstructured":"Viprakasit V, Tanphaichitr VS, Mahasandana C, Assteerawatt A, Suwantol L, Veerakul G, Kankirawatana S, Pung-Amritt P, Suvatte V: Linear growth in homozygous beta-thalassemia and beta-thalassemia\/hemoglobin E patients under different treatment regimens. J Med Assoc Thai. 2001, 84: 929-941.","journal-title":"J Med Assoc Thai"},{"key":"131_CR40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000347177","volume":"130","author":"XL Yin","year":"2013","unstructured":"Yin XL, Zhang XH, Wu ZK, Zhao DH, Zhou YL, Yu YH, Liu TN, Fang SP, Zhou TH, Wang L, Huang J: Pulmonary hypertension risk in patients with hemoglobin H disease: low incidence and absence of correlation with splenectomy. Acta Haematol. 2013, 130: 153-159. 10.1159\/000347177.","journal-title":"Acta Haematol"},{"key":"131_CR41","first-page":"3830","volume":"110","author":"V Viprakasit","year":"2007","unstructured":"Viprakasit V, Sawathiparnich P, Sangpraypanm T, Weerakulwattana L, Kiattisakthavee P, Chaichanwatanakul K, Vatana N: Osteopenia is commonly present in prepubertal children with severe Hb E\/thalassemia despite adequate transfusion and iron chelation therapy. ASH Annual Meeting Abstracts. 2007, 110: 3830-","journal-title":"ASH Annual Meeting Abstracts"},{"key":"131_CR42","volume-title":"Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT)","author":"A Taher","year":"2013","unstructured":"Taher A, Vichinsky E, Musallam KM, Cappellini MD, Viprakasit V: Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT). 2013, Nicosia, Thalassemia International Federation"},{"key":"131_CR43","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0609.1984.tb00694.x","volume":"32","author":"SC Tso","year":"1984","unstructured":"Tso SC, Loh TT, Todd D: Iron overload in patients with haemoglobin H disease. Scand J Haematol. 1984, 32: 391-394. 10.1111\/j.1600-0609.1984.tb00694.x.","journal-title":"Scand J Haematol"},{"key":"131_CR44","first-page":"329","volume":"7","author":"V Viprakasit","year":"2013","unstructured":"Viprakasit V: Alpha thalassemia syndromes: from clinical and molecular diagnosis to bedside management. EHA Hematol Educ Program. 2013, 7: 329-338.","journal-title":"EHA Hematol Educ Program"},{"key":"131_CR45","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3324\/haematol.2012.066845","volume":"98","author":"KM Musallam","year":"2013","unstructured":"Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA: Non-transfusion-dependent thalassemias. Haematologica. 2013, 98: 833-844. 10.3324\/haematol.2012.066845.","journal-title":"Haematologica"},{"key":"131_CR46","doi-asserted-by":"crossref","unstructured":"The thalassaemia working party of the BCSH general haematology task force. J Clin Pathol. 1994, 47: 289-295. 10.1136\/jcp.47.4.289.","DOI":"10.1136\/jcp.47.4.289"},{"key":"131_CR47","doi-asserted-by":"crossref","unstructured":"The laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998, 101: 783-792. 10.1046\/j.1365-2141.1998.00809.x.","DOI":"10.1046\/j.1365-2141.1998.00809.x"},{"key":"131_CR48","first-page":"364","volume":"82","author":"G Fucharoen","year":"2004","unstructured":"Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S: A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia. Bull World Health Organ. 2004, 82: 364-372.","journal-title":"Bull World Health Organ"},{"key":"131_CR49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2141.2010.08237.x","volume":"150","author":"S O\u2019Riordan","year":"2010","unstructured":"O\u2019Riordan S, Hien TT, Miles K, Allen A, Quyen NN, Hung NQ, Anh DQ, Tuyen LN, Khoa DB, Thai CQ, Triet DM, Phu NH, Dunstan S, Peto T, Clegg J, Farrar J, Weatherall D: Large scale screening for haemoglobin disorders in southern Vietnam: implications for avoidance and management. Br J Haematol. 2010, 150: 359-364. 10.1111\/j.1365-2141.2010.08237.x.","journal-title":"Br J Haematol"},{"key":"131_CR50","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1538-7836.2009.03651.x","volume":"8","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A: Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost. 2010, 8: 54-59. 10.1111\/j.1538-7836.2009.03651.x.","journal-title":"J Thromb Haemost"},{"key":"131_CR51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0609.2011.01623.x","volume":"87","author":"KM Musallam","year":"2011","unstructured":"Musallam KM, Khoury B, Bi-Habib R, Bazzi L, Succar J, Halawi R, Hankir A, Koussa S, Taher AT: Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights. Eur J Haematol. 2011, 87: 73-79. 10.1111\/j.1600-0609.2011.01623.x.","journal-title":"Eur J Haematol"},{"key":"131_CR52","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2009.07848.x","volume":"147","author":"A Taher","year":"2009","unstructured":"Taher A, Hershko C, Cappellini MD: Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies. Br J Haematol. 2009, 147: 634-640. 10.1111\/j.1365-2141.2009.07848.x.","journal-title":"Br J Haematol"},{"key":"131_CR53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00277-005-1026-4","volume":"84","author":"A Dixit","year":"2005","unstructured":"Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP: Hydroxyurea in thalassemia intermedia-a promising therapy. Ann Hematol. 2005, 84: 441-446. 10.1007\/s00277-005-1026-4.","journal-title":"Ann Hematol"},{"key":"131_CR54","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.mph.0000174386.13109.28","volume":"27","author":"M Karimi","year":"2005","unstructured":"Karimi M, Darzi H, Yavarian M: Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol. 2005, 27: 380-385. 10.1097\/01.mph.0000174386.13109.28.","journal-title":"J Pediatr Hematol Oncol"},{"key":"131_CR55","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2141.2005.05768.x","volume":"131","author":"ST Singer","year":"2005","unstructured":"Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP: Fetal haemoglobin augmentation in E\/beta (0) thalassaemia: clinical and haematological outcome. Br J Haematol. 2005, 131: 378-388. 10.1111\/j.1365-2141.2005.05768.x.","journal-title":"Br J Haematol"},{"key":"131_CR56","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1097\/MPH.0b013e31827e8662","volume":"35","author":"SH Ansari","year":"2013","unstructured":"Ansari SH, Shamsi TS, Munzir S, Khan MT, Erum S, Perveen K, Farzana T, Ashraf M, Mehboob T, Moinuddin M: Ggamma-Xmn I polymorphism: a significant determinant of beta-thalassemia treatment without blood transfusion. J Pediatr Hematol Oncol. 2013, 35: e153-e156. 10.1097\/MPH.0b013e31827e8662.","journal-title":"J Pediatr Hematol Oncol"},{"key":"131_CR57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2010.01422.x","volume":"84","author":"N Sharma","year":"2010","unstructured":"Sharma N, Das R, Kaur J, Ahluwalia J, Trehan A, Bansal D, Panigrahi I, Marwaha RK: Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major. Eur J Haematol. 2010, 84: 531-537. 10.1111\/j.1600-0609.2010.01422.x.","journal-title":"Eur J Haematol"},{"key":"131_CR58","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3324\/haematol.13098","volume":"93","author":"A Taher","year":"2008","unstructured":"Taher A, El Rassi F, Isma\u2019eel H, Koussa S, Inati A, Cappellini MD: Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia. Haematologica. 2008, 93: 1584-1586. 10.3324\/haematol.13098.","journal-title":"Haematologica"},{"key":"131_CR59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajh.21626","volume":"85","author":"AT Taher","year":"2010","unstructured":"Taher AT, Musallam KM, Wood JC, Cappellini MD: Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients. Am J Hematol. 2010, 85: 288-290. 10.1002\/ajh.21626.","journal-title":"Am J Hematol"},{"key":"131_CR60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajh.23405","volume":"88","author":"AT Taher","year":"2013","unstructured":"Taher AT, Viprakasit V, Musallam KM, Cappellini MD: Treating iron overload in patients with non-transfusion-dependent thalassemia. Am J Hematol. 2013, 88: 409-415. 10.1002\/ajh.23405.","journal-title":"Am J Hematol"},{"key":"131_CR61","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2141.2010.08346.x","volume":"151","author":"V Ladis","year":"2010","unstructured":"Ladis V, Berdousi H, Gotsis E, Kattamis A: Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia. Br J Haematol. 2010, 151: 504-508. 10.1111\/j.1365-2141.2010.08346.x.","journal-title":"Br J Haematol"},{"key":"131_CR62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2141.2003.04412.x","volume":"122","author":"P Pootrakul","year":"2003","unstructured":"Pootrakul P, Sirankapracha P, Sankote J, Kachintorn U, Maungsub W, Sriphen K, Thakernpol K, Atisuk K, Fucharoen S, Chantraluksri U, Shalev O, Hoffbrand AV: Clinical trial of deferiprone iron chelation therapy in beta-thalassaemia\/haemoglobin E patients in Thailand. Br J Haematol. 2003, 122: 305-310. 10.1046\/j.1365-2141.2003.04412.x.","journal-title":"Br J Haematol"},{"key":"131_CR63","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1182\/blood-2012-02-412692","volume":"120","author":"AT Taher","year":"2012","unstructured":"Taher AT, Porter J, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Ros J, Zhang Y, Habr D, Cappellini MD: Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. Blood. 2012, 120: 970-977. 10.1182\/blood-2012-02-412692.","journal-title":"Blood"},{"key":"131_CR64","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2141.2000.02376.x","volume":"111","author":"MD Cappellini","year":"2000","unstructured":"Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP: Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000, 111: 467-473. 10.1046\/j.1365-2141.2000.02376.x.","journal-title":"Br J Haematol"},{"key":"131_CR65","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jinf.2001.0904","volume":"43","author":"N Bisharat","year":"2001","unstructured":"Bisharat N, Omari H, Lavi I, Raz R: Risk of infection and death among post-splenectomy patients. J Infect. 2001, 43: 182-186. 10.1053\/jinf.2001.0904.","journal-title":"J Infect"},{"key":"131_CR66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2141.2008.07126.x","volume":"141","author":"NF Olivieri","year":"2008","unstructured":"Olivieri NF, Muraca GM, O\u2019Donnell A, Premawardhena A, Fisher C, Weatherall DJ: Studies in haemoglobin E beta-thalassaemia. Br J Haematol. 2008, 141: 388-397. 10.1111\/j.1365-2141.2008.07126.x.","journal-title":"Br J Haematol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0131-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-014-0131-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-014-0131-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T04:47:09Z","timestamp":1717390029000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-014-0131-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,30]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["131"],"URL":"https:\/\/doi.org\/10.1186\/s13023-014-0131-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,30]]},"article-number":"131"}}